MoonLake Immunotherapeutics: Peers

The FY2025 (Dec) proxy of MoonLake Immunotherapeutics names 15 peer companies for pay. Among MoonLake Immunotherapeutics and these peers, CEO pay was the lowest of 6 and total shareholder return was 4th highest of 6.

6th highest of 6in MoonLake Immunotherapeutics and its pay peers, FY2025 (Dec) by CEO pay:

$4.9M$12.9M

4th highest of 6in MoonLake Immunotherapeutics and its pay peers, FY2025 (Dec) by total shareholder return:

$17$433

Pay peer group, FY2025 (Dec) proxy

Protagonist Therapeutics
Immunovant
Vera Therapeutics
Spyre Therapeutics
Celldex Therapeutics
Akero TherapeuticsNot disclosedNot disclosed
Apellis PharmaceuticalsNot disclosedNot disclosed
Apogee TherapeuticsNot disclosedNot disclosed
Arcus BiosciencesNot disclosedNot disclosed
Bicycle TherapeuticsNot disclosedNot disclosed
Crinetics PharmaceuticalsNot disclosedNot disclosed
Kiniksa PharmaceuticalsNot disclosedNot disclosed
PharvarisNot disclosedNot disclosed
Summit TherapeuticsNot disclosedNot disclosed
Verona PharmaNot disclosedNot disclosed
15 companies

Changes by year

FY2025 (Dec) proxy

  • RemovedAcelyrin, Inc.pay peer groupDue to M&A activity and other companies moving outside of a comparable market capitalization range, we added the eight companies marked with an asterisk in the table above and removed four companies (Acelyrin, Inc., Dice Therapeutics, Inc., Rapt Therapeutics, Inc
  • RemovedAclaris Therapeutics, Inc.pay peer groupDue to M&A activity and other companies moving outside of a comparable market capitalization range, we added the eight companies marked with an asterisk in the table above and removed four companies (Acelyrin, Inc., Dice Therapeutics, Inc., Rapt Therapeutics, Inc
  • RemovedDice Therapeutics, Inc.pay peer groupDue to M&A activity and other companies moving outside of a comparable market capitalization range, we added the eight companies marked with an asterisk in the table above and removed four companies (Acelyrin, Inc., Dice Therapeutics, Inc., Rapt Therapeutics, Inc
  • RemovedRapt Therapeutics, Inc.pay peer groupDue to M&A activity and other companies moving outside of a comparable market capitalization range, we added the eight companies marked with an asterisk in the table above and removed four companies (Acelyrin, Inc., Dice Therapeutics, Inc., Rapt Therapeutics, Inc

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.